Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PLA2G16 Antikörper (AA 1-132) (Biotin)

PLA2G16 Reaktivität: Human ELISA Wirt: Kaninchen Polyclonal Biotin
Produktnummer ABIN7155919
  • Target Alle PLA2G16 Antikörper anzeigen
    PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))
    Bindungsspezifität
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 1-132
    Reaktivität
    • 26
    • 3
    • 1
    Human
    Wirt
    • 17
    • 7
    • 2
    Kaninchen
    Klonalität
    • 21
    • 5
    Polyklonal
    Konjugat
    • 17
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser PLA2G16 Antikörper ist konjugiert mit Biotin
    Applikation
    • 15
    • 9
    • 5
    • 3
    • 3
    • 1
    • 1
    ELISA
    Kreuzreaktivität
    Human
    Aufreinigung
    >95%, Protein G purified
    Immunogen
    Recombinant Human HRAS-like suppressor 3 protein (1-132AA)
    Isotyp
    IgG
    Top Product
    Discover our top product PLA2G16 Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))
    Andere Bezeichnung
    PLA2G16 (PLA2G16 Produkte)
    Synonyme
    HRASLS3 antikoerper, HREV107 antikoerper, HRSL3 antikoerper, AdPLA antikoerper, H-REV107-1 antikoerper, HREV107-1 antikoerper, HREV107-3 antikoerper, C78643 antikoerper, Hrasls3 antikoerper, Hrev107 antikoerper, MLP-3 antikoerper, phospholipase A2 group XVI antikoerper, phospholipase A2, group XVI antikoerper, PLA2G16 antikoerper, Pla2g16 antikoerper
    Hintergrund

    Background: Exhibits PLA1/2 activity, catalyzing the calcium-independent hydrolysis of acyl groups in various phosphatidylcholines (PC) and phosphatidylethanolamine (PE). For most substrates, PLA1 activity is much higher than PLA2 activity. Specifically catalyzes the release of fatty acids from phospholipids in adipose tissue (By similarity). N- and O-acylation activity is hardly detectable. Might decrease protein phosphatase 2A (PP2A) activity.

    Aliases: Adipose specific phospholipase A2 antibody, Adipose specific PLA2 antibody, Adipose-specific phospholipase A2 antibody, AdPLA antibody, Ca independent phospholipase A1/2 antibody, Group XVI phospholipase A1/A2 antibody, Group XVI phospholipase A2 antibody, H rev 107 protein homolog antibody, H REV107 1 antibody, H-rev 107 protein homolog antibody, HRAS like suppressor 1 antibody, HRAS like suppressor 3 antibody, HRAS-like suppressor 1 antibody, HRAS-like suppressor 3 antibody, HREV107 1 antibody, HREV107 3 antibody, HREV107 antibody, HREV107-1 antibody, HREV107-3 antibody, HRSL3 antibody, HRSL3_HUMAN antibody, Phospholipase A2 group XVI antibody, Pla2g16 antibody, Renal carcinoma antigen NY REN 65 antibody, Renal carcinoma antigen NY-REN-65 antibody

    UniProt
    P53816
    Pathways
    Inositol Metabolic Process
Sie sind hier: